Premji Invest.
The $10bn evergreen family office turned AI-forward: co-led Upscale AI's $200M Series A to unicorn, led GIVA and Dezerv, partial-exited iD Fresh to Apax at ~₹1,500 Cr, quiet capital whose returns fund the Azim Premji Foundation.
GW GP Score
Premji Invest is India's largest single-family investment office running a genuinely cross-cycle book: public equities, PE, growth, and now an explicit AI allocation across a $10bn base. The 2025-26 record shows both barrels: US AI infrastructure (Upscale AI seed-to-unicorn in months, Hippocratic AI) and Indian consumer/fintech compounders (GIVA led twice, Dezerv, TVS Credit, Akasa Air). Evergreen structure means no DPI clock; the philanthropic beneficiary means reputational conservatism. The 2025-26 push into early-stage tech under an ex-Lightspeed hire is the interesting drift: the office is moving up the risk curve exactly as the cycle turns.
Fundraise first: do not underwrite the next vintage until the capital base is visible.
Portfolio quality depends on a narrow theme; the right comp is concentration risk, not headline unicorn count.
No named analyst override yet; current view is generated from the scored dossier and should be refreshed when the next primary source lands.
Hippocratic AI round role: unconfirmed.
Early-stage practice build-out under Pahwa: first cheques.
Key-institution risk: strategy continuity beyond Kurien's tenure is unarticulated publicly.
Computed from current dossier sources; analyst override pending.
India's quietest large allocator, executing a visible AI pivot at pace with permanent capital. Graded on counterparty evidence rather than disclosed returns.
FirstCry, GIVA, TVS Credit, Upscale: quality over quantity
iD Fresh ~₹1,500 Cr + FirstCry OFS: real, low-cadence
AI allocation executing; consumer/fintech core defensive
31 deals in 18 months from permanent capital
Kurien 9 years in seat; deep partner bench; zero drama
Portfolio quality 25% · Exit realisation 30% · Sector positioning 15% · Capital velocity 15% · Franchise stability 15%: see the full GP Score methodology · compare this firm →
Pressure catalysts, fund status or evidence gaps outweigh current positives; score support depends on the next verification cycle.
GIVA liquidity clears with credible OFS/block-sale evidence.
Separate broad PE-VC softness from venture AI strength before changing sector-positioning scores.
Hippocratic AI round role: unconfirmed.
You can't invest with it, but its entries are diligence gold: Premji leading a round is the strongest quiet-capital validation in India, and its GIVA/Dezerv cap tables show which growth assets patient money believes compound.
Key-institution risk: strategy continuity beyond Kurien's tenure is unarticulated publicly.
Hippocratic AI round role: unconfirmed.
Coverage initiated: inaugural GW GP Score.
Catalyst exposure · latest source pressure
Recent public evidence mapped to this GP. Read this before reading the position table: it is where the score can move next.
Keep the file warm; current events cut both ways or are not yet material enough to move score.
Attribution0 positive catalyst(s), 1 pressure catalyst(s); top driver: India PE-VC value down 5% YoY in H1 CY2026.
The broad private-capital backdrop is selective rather than euphoric; fundraising and mark support now need firm-specific proof.
Score pressureRaises the bar for weak-DPI managers and stale flagship vehicles; rewards funds with fresh closes or visible exits.
Separate broad PE-VC softness from venture AI strength before changing sector-positioning scores.
The funds
$10bn+ evergreen across 1 tracked vehicles.
| Vehicle | Vintage | Size | Stage | Note |
|---|---|---|---|---|
| Evergreen (single-family office) | 2006Foundation era | $10bn+ | Public + PE + VC | No external LPs; Wipro-derived capital; ~77 staff, 14 partners |
Closest booksKenro Capital (1 shared) · Creaegis (1 shared) · India Quotient (1 shared)computed · E
Fund analytics · LP underwriting screen
Computed from the public dossier: vehicle cadence, realised exits, mark drift, concentration and franchise stability. All computed signals are GW estimates.
No fresh flagship close found after the 2021-22 cycle-top window.
Next liquidityGIVA · The Sleep Company
2 visible exit events since Jul 2024.
No fresh flagship close found after the 2021-22 cycle-top window.
6 up / 2 flat / 0 down tracked signals.
No senior departure flagged in key people.
6 up / 2 flat / 0 down
2 events since Jul 2024
Largest tracked active exposure
Higher spread = less balanced franchise
Pre-unicorn pricing; discovery-cost entries
Led twice, participated in Creaegis-led Series C: four tracked firms now on this cap table
Co-held with Fireside
No 2025-26 cited source found in labels; refresh priority.
2 visible events tracked.
9 representative positions tracked.
No departure signal structured.
Fund-level DPI/TVPI is usually not public; proxy remains estimated.
Peer median 2 · +0
Peer median 2 · +0
Peer median 74 · -2
Peer median 62 · +14
Peer median 0 · +0
Diligence agenda · how this view can change
The live research question, the proof required, and the source standard. This prevents a GP score from becoming a stale label.
No 2025-26 cited source is structured, so the score may be lagging the current fund, team or mark state.
Stale · No 2025-26 cited source found in labels; refresh priority.
Find a primary firm update, filing, LP disclosure or credible 2026 report that confirms fund status, exits and senior team.
Primary source first; dated secondary source acceptable only if it names the event and counterparties.
Early-stage practice build-out under Pahwa: first cheques.
GIVA: next public-market or secondary print
Evidence quality · source file health
How hard the public record is beneath this view: source mix, freshness, low-confidence fields and the next source action.
No 2025-26 source label structured.
5 total sources · 40% primary
No 2025-26 cited source found in labels; refresh priority.
Business Standard: more money into AI on $10bn base (Apr 2024)
Refresh with a dated 2025-26 source before relying on current score direction.
Source tiering follows Gravitywell policy: primary = filing/regulator/company disclosure, secondary = reputable media or research, E = Gravitywell estimate. Evidence score is a GW control metric, not an external rating.
The position book
119+ private positions plus public book. 9 tracked below.
| Company | Sector | Entered | Entry stage | Status | 12-mo signal | Latest read |
|---|---|---|---|---|---|---|
| FirstCry | Consumer & Commerce | 2020 | Pre-IPO (10.36%) | Public | → | Sold 8.6M shares in the Aug 2024 OFS (~66% gain on tendered); ~9.1% retained |
| GIVA | Consumer & Commerce | 2023 | Series B led (₹270 Cr) | Soonicorn | ▲ | Led twice, participated in Creaegis-led Series C: four tracked firms now on this cap table |
| Dezerv | Fintech | 2024 | Series B led ($32M) | Private | ▲ | Wealth management; Z47 and Elevation alongside |
| TVS Credit | Fintech | 2018 | 9.7% for ₹737 Cr | Private | → | NBFC compounder |
| Upscale AI | AI | 2026 | Series A co-led ($200M) | Unicorn | ▲ | US AI networking; seed-to-unicorn in months; with Tiger Global |
| Emversity | Consumer & Commerce | 2026 | Series A led ($30M) | Private | ▲ | Skilling; with Lightspeed, Z47 |
| Akasa Air | Logistics & Infra | 2025 | Strategic (~$125M round) | Private | · | First airline exposure; with 360 ONE, Claypond |
| SpotDraft | SaaS & Dev Tools | 2023 | Series A led ($26M) | Private | ▲ | Legal AI/CLM: co-held with Arkam |
| The Sleep Company | Consumer & Commerce | 2023 | Growth (led) | Soonicorn | ▲ | Co-held with Fireside |
Representative tracked positions reconstructed from public disclosures: not the full book. 12-mo signal is a GW estimate of mark direction from round/exit prints (E). Ownership stakes are not shown: not reliably public.
Sector exposure · where the book leans
Share of the tracked active book by normalized sector (GW estimate): read against our sector dossiers for crowding.
New cheques · 2025-26
Sixteen deals in 2025 and fifteen in H1 2026: an evergreen office running at venture-fund pace. The declared AI allocation is being executed on both continents, while the India book doubles down on branded consumer (GIVA) and financial services.
Unicorn print with Tiger, Xora
Healthcare AI: role unconfirmed
Realisation · are LPs getting paid?
Evergreen offices exit when strategics arrive, not when windows open: iD Fresh to Apax is the template. Realisation cadence is low by design; the balance sheet recycles internally.
Partial exit with TPG NewQuest to Apax (~35% for ~₹1,500 Cr): entered 2017 at ~25% for ~₹300 Cr.
Tendered 8.6M shares in the OFS at ~66% gain; retained ~9%.
No DPI clock; philanthropy-funding mandate = conservatism
Upscale unicorn + Hippocratic: the Apr 2024 declaration made real
No published marks or returns: the anti-Info-Edge
Unmeasurable from outside by design. GW read: judge it by counterparties: Apax buying its position, Tiger co-leading its AI bets, four tracked firms following it into GIVA. The quiet-capital brand is itself the moat. E.
What they're doing
Cross-cycle evergreen: public equities fund private conviction; no vintage pressure either way.
AI on both continents: US infrastructure (Upscale) + India applications, built via a dedicated early-stage practice.
Branded-consumer compounders held indefinitely (GIVA, Sleep Company, iD Fresh until Apax).
Reputational conservatism as policy: the Foundation is the ultimate LP.
What can break
Key-institution risk: strategy continuity beyond Kurien's tenure is unarticulated publicly.
US AI entries at 2026 prices (Upscale at >$1bn months after seed) carry the cycle's froth.
Opacity cuts against it in talent wars for the new early-stage practice.
Hippocratic AI round role: unconfirmed.
Early-stage practice build-out under Pahwa: first cheques.
Any Fabindia resolution (IPO shelved 2022; no update found).
Point-in-time discipline: these are the open items we could not verify at the current vintage. They get resolved: confirmed, corrected or dropped, at the next monthly refresh, never silently.
The takes · one screen, three readers
You can't invest with it, but its entries are diligence gold: Premji leading a round is the strongest quiet-capital validation in India, and its GIVA/Dezerv cap tables show which growth assets patient money believes compound.
Premji is the co-investor to invite: no exit pressure, deep pockets for follow-ons, and a brand founders trust. Its new early-stage practice is also about to compete for your Series A allocations.
Track its firsts as theme signals: first airline (Akasa), first US AI-infra unicorn (Upscale): an evergreen office moving early is a longer-duration signal than any fund's cheque.
Sourcing. Every figure is sourced and dated. We tier provenance: Primary (official, regulatory, exchange or company filings), Secondary (tier-1 industry research and reputable media), and GW estimate (our own reconstruction or opinion, labelled, never presented as external fact). We prefer primary where it exists, reconcile divergent prints to cited ranges, and hold every number point-in-time: dated, and never silently restated; revisions publish as dated changes.
Fact vs opinion. Facts vs opinion: market sizes, official prints, prices, named deals and agency ratings are sourced facts (Primary/Secondary). Scores, grades, purity weights, scenario paths and indicative sparkline points are Gravitywell's analytical opinion (GW estimate): labelled, not presented as external data.
GW GP Scores are research opinions, not investment advice, not a solicitation, and not an assessment under any SEBI regulation. Dossiers are compiled from public sources believed reliable; firms named did not participate and figures marked E are Gravitywell estimates. Point-in-time: dated to the vintage shown and never silently restated.